Racemorphan is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence. It is a Opiates substance. Levorphanol is only found in individuals that have used or taken this drug. It is a narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection. Like other mu-agonist opioids it is believed to act at receptors in the periventricular and periaqueductal gray matter in both the brain and spinal cord to alter the transmission and perception of pain. It is grouped under the following drug class(es): Schedule II controlled substances. Its therapeutic use is listed as analgesics. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include Racemorfano, Racemorphane and Orphan. It is listed as a controlled drug substance (Schedule II). Its PubChem CID is 3918.
Racemorphan
| CAS No | 297-90-5 |
|---|---|
| Molecular Formula | C17H23NO |
| Molecular Weight | 257.37 g/mol |
| Synonyms | 17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Racemorphan is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence.
The listed CAS number is 297-90-5.
The listed molecular formula is C17H23NO.
The listed molecular weight is 257.37 g/mol.
17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol.
The source lists Racemorfano, Racemorphane and Orphan.